Disc Medicine Announces Exclusive Licensing Agreement with Mabwell Therapeutics for Novel Anti-TMPRSS6 Monoclonal Antibodies to Modulate Iron Homeostasis
20th January 2023
Portfolio
This post references, or is about Disc Medicine. Find out more by clicking below
Print Article
Email Article
Save Article
